Product: Hylenex recombinant (hyaluronidase) injection, 150 USP units/mL, 4x1 mL Single Dose Vials, Rx only, Manufactured for and marketed by Halozyme, Inc., 12390 El Camino Real San Diego California 92130, Distributed by Antares Pharma, Inc., Ewing, NJ  NDC 18657-117-04
Reason for recall: cGMP Deviations: Temperature excursion
Recall initiated: 20240911
Status: Terminated
Classification: Class II
Recall type: Voluntary: Firm initiated